Geneoscopy, Inc. — Form D
Geneoscopy, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-19. The offering totals $50.5M, of which $50.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-11-19
- Form: D
- Accession: 0001787775-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $50.5M
- Amount sold: $50.5M
- Minimum investment: $1
- Investors: 85
- Date of first sale: 2021-05-10
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-421845
Issuer
- Name: Geneoscopy, Inc.
- CIK: 0001787775
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2220 WELSCH INDUSTRIAL CT., ST. LOUIS, MO, 63146
- Phone: 314-795-3265
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| ANDREW BARNELL | Director | ST. LOUIS, MO |
| ERICA BARNELL | Director | ST. LOUIS, MO |
| Drew Dennison | Director | St. Louis, MO |
| James Merselis | Director | St. Louis, MO |
| BOBBY W SANDAGE, JR. | Director | ST. LOUIS, MO |
| Najeeb Thomas | Director | Denver, CO |
| MARK ZORENSKY | Director | ST. LOUIS, MO |
| ANDREW BARNELL | Executive Officer | ST. LOUIS, MO |
| ERICA BARNELL | Executive Officer | ST. LOUIS, MO |
Other filings by this issuer (1)
More